Abstract
The purpose of the present study was to design a membrane-moderated transdermal therapeutic system (TTS) of nimodipine using 2%w / w hydroxypropyl methylcellulose (HPMC) gel as a reservoir system containing menthol as penetration enhancer and 60%v / v ethanol-water as solvent system. The flux of nimodipine was markedly increased from 35.51 μg / cm2 / h to 167.53±3.69 μg / cm2 / h with the addition of 8%w / w menthol to HPMC drug reservoir. There was an increase in the flux of nimodipine through ethylene vinyl acetate (EVA) copolymer membrane with an increase in vinyl acetate content (9 to 28%w / w) of the copolymer. The permeability flux of nimodipine from the chosen EVA 2825 (with 28%w / w vinyl acetate content) was 152.05±2.68 μg / cm2 / h, and this flux decreased to 132.69±1.45 μg / cm2 / h on application of a water-based acrylic adhesive (TACKWHITE A 4MED®) coat. However, the transdermal flux of nimodipine across EVA 2825 membrane coated with TACKWHITE A 4MEDa / rat skin composite was found to be 116.05±2.39 μg / cm2 / h, which is about 1.4 times greater than the required flux. Thus a new transdermal therapeutic system for nimodipine was designed using EVA 2825 membrane coated with a pressure-sensitive adhesive TACKWHITE 4A MED®, and 2%w / w HPMC gel as reservoir containing 8%w / w of menthol as a penetration enhancer. The in vivo evaluation of nimodipine TTS patch was carried out to find the ability of the fabricated mentholbased TTS patch in providing the predetermined plasma concentration of the drug in human volunteers. The results showed that the menthol-based TTS patch of nimodipine provided steady plasma concentration of the drug with minimal fluctuations with improved bioavailability in comparison with the immediate release tablet dosage form.
Keywords: transdermal delivery, nimodipine, menthol, membrane-moderated, bioavailability, human volunteers.
Current Drug Delivery
Title: Studies on the Transdermal Delivery of Nimodipine from a Menthol-based TTS in Human Volunteers
Volume: 1 Issue: 2
Author(s): Y. S.R. Krishnaiah and P. Bhaskar
Affiliation:
Keywords: transdermal delivery, nimodipine, menthol, membrane-moderated, bioavailability, human volunteers.
Abstract: The purpose of the present study was to design a membrane-moderated transdermal therapeutic system (TTS) of nimodipine using 2%w / w hydroxypropyl methylcellulose (HPMC) gel as a reservoir system containing menthol as penetration enhancer and 60%v / v ethanol-water as solvent system. The flux of nimodipine was markedly increased from 35.51 μg / cm2 / h to 167.53±3.69 μg / cm2 / h with the addition of 8%w / w menthol to HPMC drug reservoir. There was an increase in the flux of nimodipine through ethylene vinyl acetate (EVA) copolymer membrane with an increase in vinyl acetate content (9 to 28%w / w) of the copolymer. The permeability flux of nimodipine from the chosen EVA 2825 (with 28%w / w vinyl acetate content) was 152.05±2.68 μg / cm2 / h, and this flux decreased to 132.69±1.45 μg / cm2 / h on application of a water-based acrylic adhesive (TACKWHITE A 4MED®) coat. However, the transdermal flux of nimodipine across EVA 2825 membrane coated with TACKWHITE A 4MEDa / rat skin composite was found to be 116.05±2.39 μg / cm2 / h, which is about 1.4 times greater than the required flux. Thus a new transdermal therapeutic system for nimodipine was designed using EVA 2825 membrane coated with a pressure-sensitive adhesive TACKWHITE 4A MED®, and 2%w / w HPMC gel as reservoir containing 8%w / w of menthol as a penetration enhancer. The in vivo evaluation of nimodipine TTS patch was carried out to find the ability of the fabricated mentholbased TTS patch in providing the predetermined plasma concentration of the drug in human volunteers. The results showed that the menthol-based TTS patch of nimodipine provided steady plasma concentration of the drug with minimal fluctuations with improved bioavailability in comparison with the immediate release tablet dosage form.
Export Options
About this article
Cite this article as:
Krishnaiah S.R. Y. and Bhaskar P., Studies on the Transdermal Delivery of Nimodipine from a Menthol-based TTS in Human Volunteers, Current Drug Delivery 2004; 1 (2) . https://dx.doi.org/10.2174/1567201043479966
DOI https://dx.doi.org/10.2174/1567201043479966 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advances of natural products, bio-actives and novel drug delivery system against emerging viral infections
Due to the increasing prevalence of viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compounds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access of both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
Nanotechnology Based Chemotherapy for the treatment of Head & Neck Cancer
The escalating recurrence rates observed in Head and Neck cancer, particularly within the chemo-therapeutically treated cohort (50-60%), can be attributed to the non-selective nature of current anticancer drug delivery modalities. In this context, nanotechnology-based drug delivery systems emerge as a promising avenue for achieving precise localization of therapeutic agents to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain
CNS & Neurological Disorders - Drug Targets Cerebrovascular Complications of Diabetes: Focus on Stroke
Endocrine, Metabolic & Immune Disorders - Drug Targets Flavonoids and Dementia: An Update
Current Medicinal Chemistry Sestrins: A New Kid for Stroke Treatment?
Current Drug Delivery Cardioprotector Activity of an Esteroidal Saponin: A Scientific and Technological Prospection
Recent Patents on Biotechnology Melatonin Role in Experimental Arthritis
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications
Current Pharmaceutical Design Genomic Linkage Between Alzheimer's Disease and Type 2 Diabetes
CNS & Neurological Disorders - Drug Targets Immunopathology of Brucella Infection
Recent Patents on Anti-Infective Drug Discovery Regulation of Endothelial Nitric Oxide Synthase in Pathophysiological Conditions
Cardiovascular & Hematological Disorders-Drug Targets Current Pathogenesis of Alzheimer’s Disease and Plants Derived Neuroprotective Phytoconstituents: A Comprehensive Review
Current Psychopharmacology Cellular Membrane Microparticles: Potential Targets of Combinational Therapy for Vascular Disease
Current Vascular Pharmacology Multiple Mechanisms of Cytokine Action in Neurodegenerative and Psychiatric States: Neurochemical and Molecular Substrates
Current Pharmaceutical Design Inflammation as a Therapeutic Target in Acute Ischemic Stroke Treatment
Current Topics in Medicinal Chemistry Adenosine and ATP Receptors in the Brain
Current Topics in Medicinal Chemistry Growth Factors and Astrocytes Metabolism: Possible Roles for Platelet Derived Growth Factor
Medicinal Chemistry Management and Treatment of Cardiovascular Diseases in the Elderly
Current Pharmacogenomics and Personalized Medicine Carbon Monoxide and the Brain: Time to Rethink the Dogma
Current Pharmaceutical Design Bilateral Interrelationship of Diabetes and Periodontium
Current Diabetes Reviews The Pathophysiology of Heme in the Brain
Current Alzheimer Research